Zheyi M. Dong
State Key Laboratory Of Kidney Diseases
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Buffering effect of intensive lipid lowering on mortality risk in type 2 diabetic patients with chronic kidney disease and challenging glycemic management: a cohort study based on dual metabolic trajectories
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: July 22, 2026
Formononetin attenuates early diabetic retinal and renal microvascular injury associated with EGR1/VEGF-related endothelial responses.
Journal: Journal of ethnopharmacology
Published: June 05, 2026
Association between anti-nephrin autoantibodies and disease activity in minimal change disease.
Journal: Annals of medicine
Published: April 22, 2026
Development and multi-cohort validation of a sarcopenia-inflammation index for predicting all-cause mortality in patients with chronic kidney disease.
Journal: Frontiers in nutrition
Published: April 10, 2026
Urinary Glucose Concentration as a Predictor of Proteinuria Reduction in Chronic Kidney Disease Patients Treated with Sodium-Glucose Cotransporter 2 Inhibitors.
Journal: Kidney diseases (Basel, Switzerland)
Published: February 13, 2026
The use of the raw pulse/breathing rate ratio (PBR) as a predictor of mortality and criticality in the emergency department: a retrospective study.
Journal: BMJ open
Published: December 30, 2025
Glycemic control targets in older adults with type 2 diabetes and chronic kidney disease: a trajectory-based survival analysis of glycated hemoglobin.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: December 17, 2025
Glycemic Control Targets in Older Adults with Type 2 Diabetes and Chronic Kidney Disease: A Trajectory-Based Survival Analysis of HbA1c.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: December 17, 2025
Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis: A Systematic Review and Meta-Analysis.
Journal: Rheumatology and therapy
Published: December 11, 2025
A New Perspective on Predicting PLA2R-Associated Membranous Nephropathy Relapse: The Value of a Genetic Risk Score.
Journal: Journal of inflammation research
Published: December 06, 2025
Macular thickness is associated with pathologically confirmed diabetic nephropathy.
Journal: Photodiagnosis and photodynamic therapy
Published: August 13, 2025
Last Updated: 09/26/2026